StockData
XTL Biopharmaceuticals Ltd logo

XTL Biopharmaceuticals Ltd (XTLB) stock

XTLBNasdaqPharmaceutical Preparations
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Jun 30, 2026Score 0/30
$1.54−0.08 (-4.94%)

Close on Nov 18, 2026Market cap $14.57MP/E –Yield –

XTL Biopharmaceuticals free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2024 it was -$1.67M. The highest annual figure on record is -$851.00K in fiscal 2020.

Annual free cash flow

PeriodPeriod endValueChange
FY2024Dec 31, 2024-$1.67M–
FY2020Dec 31, 2020-$851.00K–
FY2019Dec 31, 2019-$910.00K–
FY2016Dec 31, 2016-$1.73M–
FY2015Dec 31, 2015-$1.86M–

More XTL Biopharmaceuticals figures

See a number that looks wrong?